Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced data from a poster ...

Being magnetotactic means that MMB are part of a select group of bacteria that orient their movement based on Earth's ...

Researchers have successfully developed a novel drug to restore vision. The treatment method restores vision through retinal nerve regeneration.

The nose also reportedly played an important role in ensuring humans did not become extinct. Ancient human predecessors reportedly had well developed olfactory sense which enabled them to sniff out ...

Texas' measles outbreak has brought renewed attention to the state's politically chared vaccine debate. Here's how elected ...

Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of ...

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the discontinuation of its clinical ...

Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” fourth quarter 2024 investor ...

TIGIT in particular has proved to be a tricky target for drug developers, and BeiGene's decision comes just a few months after MSD abandoned the development of its anti-TIGIT antibody vibostolimab ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on the week of April 7th, IPO Scoop reports.

Hospitals’ increased reliance on agency nurses and overtime shifts for in-house nurses appears to have implications for ...

PASADENA, Calif., April 3, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE ), the first, preeminent, longest-tenured and pioneering own ...